Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Buy These 3 Undervalued “Elephant” Stocks…Before Buffett Does: National-Oilwell Varco, Inc. (NOV), Toll Brothers Inc (TOL), AFLAC Incorporated (AFL)

Page 1 of 2

Warren Buffett wants an Elephant.

In Berkshire Hathaway Inc. (NYSE:BRK.B)‘s 2012 letter to shareholders, Buffett again stressed his desire to make a large acquisition. Given that Berkshire’s book value returns have trailed the S&P 500 during three of the last four years, it’s increasingly likely that a large acquisition will be made in 2013. At Berkshire’s size, a large acquisition is simply the easiest way to boost the bottom line.

So why not beat Buffett to the punch? Doing so would certainly boost your bottom line, as a premium would be paid for your shares.

Here are three undervalued “Elephants” that would should be bought by Berkshire, and by you.

National-Oilwell Varco, Inc. (NYSE:NOV)National-Oilwell Varco, Inc. (NYSE:NOV)

Picking “Buffett” stocks is really not a guessing game. Berkshire has made public what they look for in acquisition targets, for years. The first three things Berkshire looks for are large capitalization, consistent earnings power, and good returns on equity. Buffett’s telling us, and potential acquire-es, exactly what he looks for.

You’d be hard pressed to find any company that fits those criteria as well as National-Oilwell Varco, Inc. (NYSE:NOV).

The company provides equipment for the oil and gas sector and has been on a stellar run of superb performance, and market share gains.

National Oilwell Varco has grown earnings 9% over the past year, while growing revenue 15%. Even better, the company showed outstanding performance in 2012 with that high return on equity Buffett likes (31%), and a whopping 25% growth in earnings.

Want more good news? Well, how about the fact that I already know Buffett likes National-Oilwell Varco, Inc. (NYSE:NOV). I can say this with reasonable certainty because Berkshire already owns shares–and they’ve been buying more recently!

Why it’s a good buy now:

National-Oilwell Varco, Inc. (NYSE:NOV) is currently trading well below its 52-week high. The price is depressed, with a P/E of just 11, due largely to margin concerns. But the company is betting that those near-term pressures will lead to a long-term monopoly.

The company is taking on lower margin business lines purposefully to gain even more market share by offering a “one stop shop.” With a slew of acquisitions, the company is consolidating the industry they serve and this should lead to a stronger moat and fatter margins in the long run.

As many fools have said–NOV stands for: “No Other Vendor.” I really like that the company isn’t resting on its 60% market share, they know what they want to be (a conglomerate) and they’re staying aggressive. If you agree with this strategy, the stock is a compelling buy at these levels.

Toll Brothers Inc (NYSE:TOL)

One of the many prevailing themes in this years “letter” was that Buffett is still incredibly bullish on the U.S. economy. And we already know, with his holding in USG and Wells Fargo, that he’s optimistic about housing. So why wouldn’t he take a look at a proven, best of breed leader like Toll Brothers?

This company has a phenomenal brand identity in designing, building and selling luxury homes. With a strong return on equity of 17.25% and a market cap under 6 billion, Toll Brothers Inc (NYSE:TOL) is profitable enough to boost Berkshire’s bottom line while still leaving cash on the books.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!